Systemic effects of hypernephroma

Area of Science:

• Oncology
• Nephrology

Background:

• Hypernephromas, also known as renal cell carcinoma, can present with varied clinical manifestations.
• Traditional diagnostic criteria, including the classic triad, are often absent in patients.

Purpose of the Study:

• To investigate the systemic effects associated with hypernephromas.
• To determine the diagnostic utility of these systemic effects in early detection and follow-up care.

Main Methods:

• Retrospective analysis of 30 patients diagnosed with hypernephromas.
• Detailed examination of presenting symptoms, systemic effects, and laboratory findings.
• Correlation of tumor removal with the remission of systemic effects.

Main Results:

• 23 out of 30 patients exhibited systemic effects; for 5, these were the initial diagnostic indicators.
• Urologic complaints were less frequent (17 patients); the classic triad was not observed in any patient.
• Common systemic effects included weight loss (52%), pyrexia, elevated sedimentation rate (36%), anemia (25%), abnormal liver function, elevated alkaline phosphatase, hypertension, erythrocytosis, and hypercalcemia.

Conclusions:

• Systemic effects are crucial indicators for hypernephroma diagnosis, often preceding urologic symptoms.
• Evaluating systemic effects aids in early diagnosis and effective patient follow-up.
• Tumor resection generally leads to the remission of these paraneoplastic syndromes.